Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry

Bente Glintborg; Mikkel Østergaard; Niels Steen Krogh; Lene Dreyer; Hanne Lene Kristensen; Merete Lund Hetland; Lene Dreyer

doi:10.1136/ard.2009.124446

Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry

Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh, Lene Dreyer, Hanne Lene Kristensen, Merete Lund Hetland, Lene Dreyer

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

202 Citationer (Scopus)

Abstract

To use prospectively registered data from the Danish nationwide rheumatological database (DANBIO) to describe disease activity, clinical response, treatment duration and predictors of drug survival (ie, number of days individual patients maintained treatment) and clinical response among patients with ankylosing spondylitis (AS) receiving their first treatment series with a tumour necrosis factor a (TNFa) inhibitor.

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	69
Udgave nummer	11
Sider (fra-til)	2002-8
Antal sider	7
ISSN	0003-4967
DOI	https://doi.org/10.1136/ard.2009.124446
Status	Udgivet - 1 nov. 2010

Adgang til dokumentet

10.1136/ard.2009.124446

Citationsformater

Glintborg, B., Østergaard, M., Krogh, N. S., Dreyer, L., Kristensen, H. L., Hetland, M. L., & Dreyer, L. (2010). Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry. Annals of the Rheumatic Diseases, 69(11), 2002-8. https://doi.org/10.1136/ard.2009.124446

Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry. / Glintborg, Bente; Østergaard, Mikkel; Krogh, Niels Steen et al.
I: Annals of the Rheumatic Diseases, Bind 69, Nr. 11, 01.11.2010, s. 2002-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Glintborg, B, Østergaard, M, Krogh, NS, Dreyer, L, Kristensen, HL, Hetland, ML & Dreyer, L 2010, 'Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry', Annals of the Rheumatic Diseases, bind 69, nr. 11, s. 2002-8. https://doi.org/10.1136/ard.2009.124446

Glintborg B, Østergaard M, Krogh NS, Dreyer L, Kristensen HL, Hetland ML et al. Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry. Annals of the Rheumatic Diseases. 2010 nov. 1;69(11):2002-8. doi: 10.1136/ard.2009.124446

@article{30070d950a0447829c46c56d573541e2,

title = "Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry",

abstract = "To use prospectively registered data from the Danish nationwide rheumatological database (DANBIO) to describe disease activity, clinical response, treatment duration and predictors of drug survival (ie, number of days individual patients maintained treatment) and clinical response among patients with ankylosing spondylitis (AS) receiving their first treatment series with a tumour necrosis factor a (TNFa) inhibitor.",

author = "Bente Glintborg and Mikkel {\O}stergaard and Krogh, {Niels Steen} and Lene Dreyer and Kristensen, {Hanne Lene} and Hetland, {Merete Lund} and Lene Dreyer",

year = "2010",

month = nov,

day = "1",

doi = "10.1136/ard.2009.124446",

language = "English",

volume = "69",

pages = "2002--8",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "11",

}

TY - JOUR

T1 - Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry

AU - Glintborg, Bente

AU - Østergaard, Mikkel

AU - Krogh, Niels Steen

AU - Dreyer, Lene

AU - Kristensen, Hanne Lene

AU - Hetland, Merete Lund

AU - Dreyer, Lene

PY - 2010/11/1

Y1 - 2010/11/1

N2 - To use prospectively registered data from the Danish nationwide rheumatological database (DANBIO) to describe disease activity, clinical response, treatment duration and predictors of drug survival (ie, number of days individual patients maintained treatment) and clinical response among patients with ankylosing spondylitis (AS) receiving their first treatment series with a tumour necrosis factor a (TNFa) inhibitor.

AB - To use prospectively registered data from the Danish nationwide rheumatological database (DANBIO) to describe disease activity, clinical response, treatment duration and predictors of drug survival (ie, number of days individual patients maintained treatment) and clinical response among patients with ankylosing spondylitis (AS) receiving their first treatment series with a tumour necrosis factor a (TNFa) inhibitor.

U2 - 10.1136/ard.2009.124446

DO - 10.1136/ard.2009.124446

M3 - Journal article

SN - 0003-4967

VL - 69

SP - 2002

EP - 2008

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 11

ER -